arrow
K

Kentaro Igarashi

University of California San Diego
H指数:38
被引数:4,669

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human fibrosarcoma cells selected for ultra-high doxorubicin resistance; acquire trabectedin cross-resistance; remain sensitive to recombinant methioninase; and have increased c-MYC expression

人纤维肉瘤细胞经超高效多柔比星耐药筛选;获得曲贝替定交叉耐药性;对重组蛋氨酸酶仍敏感;且c-MYC表达增加

2025-12-080
OAAI
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts

重组蛋氨酸酶与顺铂和伊维菌素组合的选择性协同作用,能够清除肺癌细胞,但对正常成纤维细胞无协同作用且效果有限。

2025-12-010
PRE
Rapid Eradication of Extensive Spinal Metastases in a Prostate-Cancer Patient Taking Androgen-deprivation Therapy, Chemotherapy, and Oral Recombinant Methioninase on a Low-Methionine Diet

在一例接受雄激素剥夺疗法、化疗和低甲硫氨酸饮食下口服重组甲硫氨酸酶的前列腺癌患者中,快速清除广泛脊柱转移灶

2025-12-010
PRE
FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient

FDG-和MET-PET成像揭示一名58岁患者的原发子宫内膜癌中存在葡萄糖和蛋氨酸成瘾,以及腹主动脉旁淋巴结转移中仅存在蛋氨酸成瘾。

2025-12-010
PRE
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts

Asano Y,Han Q,Li S,Mizuta K,Kang BM,Kim JS,等。重组甲硫氨酸酶与抗寄生虫药物伊维菌素和氯喹的三联组合可选择性清除胰腺癌细胞,同时保护正常成纤维细胞。Anticancer Res. (2025) 45:4791–802. doi: 10.21873/anticanres.17828

2025-11-011
PRE
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
2025-11-011
PRE
A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy

使用99mTc-MDP闪烁显像术对恶性骨肿瘤切除后的冷冻自体肿瘤进行重建的可行性分析

2022-10-143
PRE
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study
2022-09-216
OAAI